Eosinophils and neutrophils
暂无分享,去创建一个
[1] A. Kay,et al. Human granulocyte/pollen-binding protein. Recognition and identification as transferrin. , 1984, The Journal of clinical investigation.
[2] A. Kay,et al. Immunologic release of neutrophil chemotactic activity from human lung tissue. , 1983, The Journal of allergy and clinical immunology.
[3] Nikolaos S. Papageorgiou,et al. Neutrophil chemotactic activity in milk-induced asthma. , 1983, The Journal of allergy and clinical immunology.
[4] Nikolaos S. Papageorgiou,et al. Exercise-induced late asthmatic reactions with neutrophil chemotactic activity. , 1983, The New England journal of medicine.
[5] S. Durham,et al. 231 Immunological studies of antigen-induced late asthmatic reactions , 1983 .
[6] K. E. Holley,et al. IDENTIFICATION BY IMMUNOFLUORESCENCE OF EOSINOPHIL GRANULE MAJOR BASIC PROTEIN IN LUNG TISSUES OF PATIENTS WITH BRONCHIAL ASTHMA , 1982, The Lancet.
[7] W. Henderson,et al. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. , 1982, Journal of immunology.
[8] G. Gleich,et al. Formation of Charcot-Leyden crystals by human basophils , 1982, The Journal of experimental medicine.
[9] D. Grove. What is the Relationship between Asthma and Worms? , 1982, Allergy.
[10] M. Walport,et al. Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma. , 1982, The Journal of clinical investigation.
[11] A. B. Kay,et al. Neutrophil chemotactic activity in antigen-induced late asthmatic reactions. , 1982, The New England journal of medicine.
[12] E. Goetzl,et al. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. , 1982, Clinical and experimental immunology.
[13] W. Henderson,et al. Leukotriene generation by eosinophils , 1982, The Journal of experimental medicine.
[14] M. Dierich,et al. Differentiation of C3b receptors on human lymphocytes, phagocytes, erythrocytes and renal glomerulus cells by monoclonal antibodies. , 1982, Immunology.
[15] P. Ind,et al. A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics. , 1982, The Journal of allergy and clinical immunology.
[16] I. Olsson,et al. Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro , 1981, Parasite immunology.
[17] F. Hirata. The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. , 1981, The Journal of biological chemistry.
[18] D. Durack,et al. Purification of human eosinophil-derived neurotoxin. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[19] G. Crompton,et al. Corticosteroid resistance in chronic asthma , 1981, British medical journal.
[20] A. B. Kay,et al. Corticosteroid-resistant chronic asthma and monocyte complement receptors. , 1981, Clinical and experimental immunology.
[21] A. Capron,et al. Tetrapeptides of the eosinophil chemotactic factor of anaphylaxis (ECF-A) enhance eosinophil Fc receptor , 1981, Nature.
[22] E. Goetzl,et al. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[23] E. Chi,et al. Eosinophil peroxidase-induced mast cell secretion , 1980, The Journal of experimental medicine.
[24] F. Hirata,et al. A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Loegering,et al. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. , 1980, Laboratory investigation; a journal of technical methods and pathology.
[26] D. Loegering,et al. Cytotoxic properties of the eosinophil major basic protein. , 1979, Journal of immunology.
[27] M. Vadas,et al. Interactions between human eosinophils and schistosomula of schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence , 1979, The Journal of experimental medicine.
[28] A. Kay. The role of the eosinophil. , 1979, The Journal of allergy and clinical immunology.
[29] G. J. Blackwell,et al. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation , 1979, Nature.
[30] D. Loegering,et al. Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. , 1979, Journal of immunology.
[31] A. R. Anwar,et al. Enhancement of human eosinophil complement receptors by pharmacologic mediators. , 1978, Journal of immunology.
[32] R. Dahl,et al. Variations of Blood Eosinophils and Eosinophil Cationic Protein in Serum in Patients with Bronchial Asthma , 1978, Allergy.
[33] D. McLaren,et al. Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasitic helminths (Schistosoma mansoni, Trichinella spiralis and Nippostrongylus brasiliensis). , 1977, Clinical and experimental immunology.
[34] A. Kay,et al. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors , 1977, Nature.
[35] A. Kay,et al. Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. , 1977, Journal of immunology.
[36] A. Mahmoud,et al. Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. , 1977, The Journal of clinical investigation.
[37] A. Kay,et al. Cutaneous eosinophil accumulation in atopic and non‐atopic individuals: the effect of an ECF‐A tetrapeptide and histamine , 1977, Clinical allergy.
[38] B. Zweiman,et al. Release of neutrophil chemotactic activity during immediate hypersensitivity reactions in humans. , 1977, Annals of internal medicine.
[39] B. Zweiman,et al. Histologic studies of human skin test responses to ragweed and compound 48/80. III. Effects of alternate-day steroid therapy. , 1976, The Journal of allergy and clinical immunology.
[40] H. Colten,et al. Histamine metabolism. II. Cellular and subcellular localization of the catabolic enzymes, histaminase and histamine methyl transferase, in human leukocytes. , 1976, The Journal of allergy and clinical immunology.
[41] E. Goetzl,et al. Isolation of human eosinophil phospholipase D. , 1976, The Journal of clinical investigation.
[42] R. Clark,et al. The selective eosinophil chemotactic activity of histamine , 1975, The Journal of experimental medicine.
[43] E. Goetzl,et al. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. , 1975, Proceedings of the National Academy of Sciences of the United States of America.
[44] S. Douglas,et al. Surface Features of Human Eosinophils: a Scanning and Transmission Electron Microscopic Study of a Case of Eosinophilia , 1975, British journal of haematology.
[45] E D Robin,et al. Total eosinophil counts in the management of bronchial asthma. , 1975, The New England journal of medicine.
[46] E. Goetzl,et al. Inactivation of slow reacting substance of anaphylaxis by human eosinophil arylsulfatase. , 1975, Journal of immunology.
[47] A. Kay,et al. The Identification of Fibrinopeptide B as a Chemotactic Agent Derived from Human Fibrinogen , 1974, British journal of haematology.
[48] I. Olsson,et al. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. , 1974, Blood.
[49] W. Franklin. Treatment of severe asthma. , 1974, The New England journal of medicine.
[50] Spicer Ss,et al. Cytochemical and ultrastructural identification of a small type granule in human late eosinophils. , 1974 .
[51] K. de Vries,et al. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. , 1971, The Journal of allergy and clinical immunology.
[52] K. Ishizaka,et al. Mechanisms of passive sensitization. I. Presence of IgE and IgG molecules on human leukocytes. , 1970, Journal of immunology.
[53] R. Lehrer,et al. Myeloperoxidase deficiency. Immunologic study of a genetic leukocyte defect. , 1970, The New England journal of medicine.
[54] A. Kay. Studies on eosinophil leucocyte migration. I. Eosinophil and neutrophil accumulation following antigen-antibody reactions in guinea-pig skin. , 1970, Clinical and experimental immunology.
[55] R. Cotran,et al. THE ENTRY OF GRANULE-ASSOCIATED PEROXIDASE INTO THE PHAGOCYTIC VACUOLES OF EOSINOPHILS , 1969, The Journal of experimental medicine.
[56] F. C. Lowell. Clinical aspects of eosinophilia in atopic disease. , 1967, Journal of the American Medical Association (JAMA).
[57] J. Trentin,et al. Hemopoietic spleen colony studies. I. Growth and differentiation. , 1967, Developmental biology.
[58] G. Cartwright,et al. BLOOD GRANULOCYTE KINETICS IN CONDITIONS ASSOCIATED WITH GRANULOCYTOSIS * , 1964, Annals of the New York Academy of Sciences.
[59] J. G. Hirsch,et al. MOTION PICTURE STUDIES ON DEGRANULATION OF HORSE EOSINOPHILS DURING PHAGOCYTOSIS , 1963, The Journal of experimental medicine.
[60] R. K. Archer,et al. Studies on the peroxidase reaction of living eosinophils and other leucocytes. , 1963, Acta haematologica.
[61] M. Behrens,et al. Gewinnung der “eosinophilen Substanz” aus isolierten eosinophilen Granulozyten des Pferdeblutes , 1962 .
[62] W. Valentine,et al. Human Leucocyte Arylsulphatase Activity * † , 1962, British journal of haematology.
[63] J. Thiery,et al. Electron microscopy of human white blood cells and their stem cells. , 1961, International review of cytology.
[64] B. J. Bryant,et al. Autoradiographic Studies of Leukocyte Formation.∗ , 1958, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[65] R. Moore,et al. Electron microscopy of formed elements of normal human blood. , 1957, Blood.